等位基因
人类白细胞抗原
GenBank公司
打字
遗传学
聚合酶链反应
生物
HLA-B
外显子
DNA测序
低聚物限制
寡核苷酸
序列(生物学)
HLA-A
分子生物学
HLA-B抗原
基因
抗原
作者
Yonghong Song,Yongxin Mao,Kui Dong,Xiaojian Chen,Yanxia Gu
出处
期刊:PubMed
[National Institutes of Health]
日期:2013-04-01
卷期号:30 (2): 168-71
被引量:3
标识
DOI:10.3760/cma.j.issn.1003-9406.2013.04.010
摘要
OBJECTIVE: To analyze potential mutations of uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) gene in patients with unconjugated hyperbilirubinemia, and to explore the correlation between the mutations and total serum bilirubin levels. METHODS: Genomic DNA was extracted from peripheral blood samples of patients. Coding sequence and promoter region of the UGT1A1 gene were amplified. Mutations were identified through DNA sequencing. RESULTS: Mutations of the UGT1A1 gene were found in 46 out of 61 patients with unconjugated hyperbilirubinemia. Five types of mutations were detected, with a decreasing order of 211G>A, TA insertion in the TATAA promoter element, 686C>A, 1091C>T and 1352C>T. Compared with those carrying a single homozygous mutation or compound heterozygous mutations, total serum bilirubin was higher in those carrying a homozygous mutation in combination with other heterozygous mutations (P< 0.05). Based on the UGT1A1 gene mutations and level of total serum bilirubin, 44 patients were diagnosed with Gilbert syndrome, and 2 were diagnosed with Crigler-Najjar syndrome type 2. CONCLUSION: The level of total serum bilirubin is correlated with the number of UGT1A1 gene mutations as well as their heterozygous or homozygous status.
科研通智能强力驱动
Strongly Powered by AbleSci AI